In late 2019 I wrote a post titled How to Export Medical Cannabis Internationally. That post got a lot of play with reporters and also prospective clients. We ended up with a couple of fascinating projects, one of which required registration under the U.S. Foreign Agents Registration Act (didn’t see that one coming) and another

The post How to Export Medical Cannabis appeared first on Harris Bricken Sliwoski LLP.

It should come as no surprise that the number of applications for cannabis patents has been steadily increasing in recent years. In this post we discuss the basics of the subject, with a focus in the United States. While patent systems usually bear some similarities, some of the details may be different in other countries.

The post Cannabis Patents Q&A appeared first on Harris Bricken Sliwoski LLP.

When issues arise, many people think filing a lawsuit is the answer. That will initiate the litigation process, which will most likely involve an exchange of information and documents, the process of taking depositions, and probably some motion practice along the way.  While in some cases it certainly is, we typically counsel new clients (and

The post Hemp Litigation: Pre-Lawsuit Options appeared first on Harris Bricken Sliwoski LLP.

Yesterday, March 31, 2022, the House of Representatives again voted to end federal prohibition of marijuana by removing it from the list of banned substances. The bill—the Marijuana Opportunity Reinvestment and Expungement Act (the MORE Act)—passed by a vote of 220-204, largely along party lines. Next the bill goes to the Senate for approval, where

The post Cannabis Legalization: MORE Act Again Clears the House appeared first on Harris Bricken Sliwoski LLP.